Total Payments
$10,099
2024 Payments
$2,172
Companies
40
Transactions
448
Medicare Patients
1,502
Medicare Billing
$96,995
Payment Breakdown by Category
Food & Beverage$10,071 (99.7%)
Education$27.40 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,071 | 443 | 99.7% |
| Education | $27.40 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,494 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,370 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,087 | 38 | $0 (2024) |
| Lilly USA, LLC | $1,004 | 38 | $0 (2024) |
| Amgen Inc. | $698.88 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $656.64 | 36 | $0 (2023) |
| ABBVIE INC. | $567.30 | 22 | $0 (2024) |
| PFIZER INC. | $514.75 | 32 | $0 (2024) |
| Novo Nordisk Inc | $450.24 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $415.31 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,172 | 76 | Boehringer Ingelheim Pharmaceuticals, Inc. ($387.57) |
| 2023 | $2,854 | 95 | GlaxoSmithKline, LLC. ($581.30) |
| 2022 | $1,107 | 30 | Amgen Inc. ($287.44) |
| 2020 | $218.43 | 11 | Lilly USA, LLC ($55.25) |
| 2019 | $1,273 | 83 | AstraZeneca Pharmaceuticals LP ($281.81) |
| 2018 | $1,091 | 67 | GlaxoSmithKline, LLC. ($196.20) |
| 2017 | $1,383 | 86 | Janssen Pharmaceuticals, Inc ($275.94) |
All Payment Transactions
448 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: PAIN | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $150.52 | General |
| Category: Diabetes Care | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Oncology | ||||||
| 08/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 328 | 568 | $87,340 | $20,171 |
| 2022 | 9 | 411 | 652 | $97,876 | $27,615 |
| 2021 | 8 | 392 | 609 | $73,316 | $25,213 |
| 2020 | 9 | 371 | 573 | $67,223 | $23,996 |
Total Patients
1,502
Total Services
2,402
Medicare Billing
$96,995
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 221 | $63,648 | $12,057 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 49 | $9,947 | $2,375 | 23.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $7,644 | $1,956 | 25.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 104 | 207 | $1,242 | $1,217 | 98.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $2,197 | $935.09 | 42.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,275 | $855.00 | 67.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $765.00 | $513.00 | 67.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 12 | 12 | $622.00 | $261.99 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 191 | $38,773 | $9,353 | 24.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 32 | 32 | $20,416 | $8,929 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 97 | $27,936 | $5,452 | 19.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 34 | $1,734 | $1,149 | 66.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $4,704 | $919.40 | 19.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 121 | 231 | $1,386 | $677.32 | 48.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 22 | 24 | $1,160 | $503.92 | 43.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $714.00 | $476.81 | 66.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $1,053 | $154.76 | 14.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 164 | $32,342 | $11,737 | 36.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 120 | $32,727 | $9,607 | 29.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $2,020 | $1,221 | 60.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 46 | 46 | $2,250 | $890.22 | 39.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 36 | 36 | $1,440 | $737.18 | 51.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 104 | 207 | $1,242 | $616.70 | 49.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $452.00 | $230.46 | 51.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 13 | $843.00 | $174.07 | 20.6% |
About Dr. Keith Lee, MD
Dr. Keith Lee, MD is a Internal Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699766188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Lee, MD has received a total of $10,099 in payments from pharmaceutical and medical device companies, with $2,172 received in 2024. These payments were reported across 448 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($10,071).
As a Medicare-enrolled provider, Lee has provided services to 1,502 Medicare beneficiaries, totaling 2,402 services with total Medicare billing of $96,995. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Irvine, CA
- Active Since 11/02/2005
- Last Updated 10/13/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699766188
Products in Payments
- FARXIGA (Drug) $1,185
- JARDIANCE (Drug) $908.66
- XARELTO (Drug) $581.90
- TRELEGY ELLIPTA (Drug) $479.12
- Enbrel (Biological) $307.51
- MOUNJARO (Drug) $293.44
- TRULICITY (Drug) $280.30
- Otezla (Drug) $262.69
- JANUVIA (Drug) $223.94
- Wegovy (Drug) $219.31
- QULIPTA (Drug) $211.63
- OFEV (Drug) $199.41
- BREO (Drug) $192.68
- ANORO (Drug) $188.98
- BOTOX (Biological) $171.15
- ELIQUIS (Drug) $166.87
- Ozempic (Drug) $162.51
- UBRELVY (Drug) $152.73
- FREESTYLE LIBRE 3 (Device) $150.52
- AIRSUPRA (Drug) $142.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irvine
Dr. Tung Ngo, Do, DO
Internal Medicine — Payments: $4.9M
Internal Medicine $4.9M
Rashmi Kumar, Md, MD
Internal Medicine — Payments: $121,958
Internal Medicine $121,958
Dr. Irene Kang, M.d, M.D
Internal Medicine — Payments: $55,000
Internal Medicine $55,000
Dr. Behdad Akbarpour, Md, MD
Internal Medicine — Payments: $34,097
Internal Medicine $34,097
Dr. Maher Kassis, M.d, M.D
Internal Medicine — Payments: $30,310
Internal Medicine $30,310
Dr. Shanta Chawla, Md, MD
Internal Medicine — Payments: $17,484
Internal Medicine $17,484